Vimta Labs

₹506.75As of Sun 8 Nov 2026, 12:00 UTC

NSE:VIMTALABSHealthcare

Country India

PE (Fwd) 24.85

TSR 10Y CAGR 25.85%

Div yield 0.39%

ROE —

Diagnostics & Research

Beta (5Y) (0.10)

PE TTM 29.46

TSR TTM (29.88%)

Mkt cap ₹22.50B

ROIC —

SE Grade™

Value

Quality

Moat

—

1Y Price

Reference

₹564

11.25%

(70.84%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

5Y

10Y

Peers

4.097

Revenue₹B

—

—

—

—

—

2.787

3.190

2.896

3.454

4.097

4.476

10.11%

10.11%

10

18.62

Revenue growth%

—

—

—

—

—

—

14.46

(9.22)

19.25

18.62

9.25

16.54

—

70

75.41

Gross margin%

—

—

—

—

—

67.60

72.70

75.38

75.24

75.41

75.57

75.24

75.24

83

24.48

Operating margin%

—

—

—

—

—

20.68

20.39

21.38

25.49

24.48

24.47

21.38

21.38

90

18.92

Net margin%

—

—

—

—

—

14.83

15.10

16.85

19.50

18.92

18.93

16.85

16.85

100

29.46

P/E ratio (avg)x

—

—

—

—

—

16.60

18.29

21.80

26.56

38.58

26.95

21.80

21.80

67

22.77

EV/EBITx

—

—

—

—

—

11.91

13.55

17.19

20.31

29.82

20.85

17.19

17.19

68

—

FCF yield (avg)%

—

—

—

—

—

—

—

—

—

—

—

—

—

53

—

FCF margin%

—

—

—

—

—

—

—

—

—

—

—

—

—

62

—

FCF / Net incomex

—

—

—

—

—

—

—

—

—

—

—

—

—

28

—

ROIC%

—

—

—

—

—

—

—

—

—

—

—

—

—

93

—

Return on equity%

—

—

—

—

—

—

—

—

—

—

—

—

—

93

—

Return on assets%

—

—

—

—

—

—

—

—

—

—

—

—

—

93

17.20

EPS₹

—

—

—

—

—

9.16

10.68

10.86

14.96

17.20

18.80

17.06%

17.06%

—

15.00

EPS growth%

—

—

—

—

—

—

16.54

1.70

37.78

15.00

9.30

15.77

—

42

—

Bookvalue per sh₹

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

FCF per share₹

—

—

—

—

—

—

—

—

—

—

—

—

—

—

2.00

Dividend per sh₹

—

—

—

—

—

1.00

1.00

1.00

1.00

2.00

2.19

18.92%

18.92%

—

0.39

Div yield (avg)%

—

—

—

—

—

0.66

0.51

0.42

0.25

0.30

0.43

0.42

0.42

13

11.63

Payout ratio%

—

—

—

—

—

10.92

9.37

9.21

6.70

11.63

11.63

9.37

9.37

20

45.06

Shares (diluted)M

—

—

—

—

—

45.12

45.13

44.96

45.02

45.06

◌45.06

(0.03%)

(0.03%)

46

(0.09)

Buyback yield%

—

—

—

—

—

—

(0.01)

0.37

(0.14)

(0.09)

◌—

(0.05)

—

46

—

D/E ratiox

—

—

—

—

—

—

—

—

—

—

—

—

—

79

22.83

Enterprise value₹B

—

—

—

—

—

6.863

8.811

10.64

17.88

29.91

22.83

44.48%

44.48%

41

—

LT debt₹M

—

—

—

—

—

—

—

—

—

—

—

—

—

17

Peers (US$236.8M)

Cap (US$)

PE

Thyrocare Technologies…

837.4M

55.15x

Suraksha Diagnostic…

185.8M

48.70x

Krsnaa Diagnostics…

163.3M

15.78x

Healius Limited

249.4M

—

Capital

TTM

5Y

10Y

Leveragex

—

—

—

EBIT/Intx

122.2

53.97

53.97

Own earn%

—

—

—

Sh yield%

0.31

0.36

0.36

Owners

Insiders/Inst%

35.48

4.52

Short interest%

—

SBC / revenue%

0.83

Record

10Y

Profitable years

5/5

Revenue growth years

3/4

EPS growth years

4/4

Dividend streakyrs

0

Op margin range%

20–25

$1 testx

—

Incr. ROIC%

—

Vimta Labs Limited provides contract research and testing services in India and internationally.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹4.097B

10.11%

1.00×

Cost of revenue

₹1.007B

2.76%

0.76×

Operating expenses

₹2.087B

12.39%

1.09×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

-

Return on capital

n/m

-

Spread over hurdle

n/m

-